Skip to main content
Erschienen in: Health and Quality of Life Outcomes 1/2021

Open Access 01.12.2021 | Research

Gender difference in the association between cough severity and quality of life among patients with postinfectious cough

verfasst von: Wei Liu, Qinqin Wu, Bing Mao, Hongli Jiang

Erschienen in: Health and Quality of Life Outcomes | Ausgabe 1/2021

Abstract

Background

Despite close link exists between cough severity and quality of life (QoL), whether gender difference is implied in the effect of cough on QoL has not been studied yet. This study primarily aims to investigate whether the association between cough severity and QoL is modified by gender in patients with postinfectious cough.

Methods

Secondary analyses were performed in 180 participants with postinfectious cough in a multisite randomized controlled trial. Baseline demographics, clinical characteristics and score of cough specific quality of life questionnaire (CQLQ) were collected. Linear regression analyses were conducted to examine gender difference in CQLQ score and the association between cough severity and CQLQ score.

Results

Difference between women and men was not significant in CQLQ total score in the unadjusted analysis (P = 0.077). Women had a 2.20-point higher CQLQ total score than men (95% confidence interval (CI) 0.11–4.30; P = 0.039), after adjusting for age, cough duration, cough severity, and clinical center. Gender significantly modified the association between cough severity and CQLQ total score (coefficient 1.80, 95% CI 0.29–3.30; P = 0.020), after adjusting for age, cough duration, and study center. An increase of 1-point in cough severity was associated with a 2.55-point (95% CI 1.16–3.95) increase in CQLQ total score in women versus a 1.26-point (95% CI 0.20–2.31) increase in men (P = 0.020).

Conclusions

Female sex may be associated with worse QoL than men, and women’s QoL may be more significantly impaired as cough symptom deteriorates. Gender difference should be taken into account in the clinical settings and research of cough and cough related QoL.
Trial registration: Chinese Clinical Trial Registry, ChiCTRTRC12002297. Registered 19 June 2012, http://​www.​chictr.​org.​cn/​abouten.​aspx.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CI
Confidence interval
CQLQ
Cough specific quality of life questionnaire
QoL
Quality of life
VAS
Visual analogue scale

Background

Cough is among the most common respiratory symptoms that lead patients to seek medical help in primary care and respiratory specialist clinics [14]. Although fatal complications are rare, unremitting cough is always frustrating and bothersome. Loss of sleep, exhaustion, irritability, urinary incontinence, cough syncope, social disability, and inability to perform daily activities are some of the negative outcomes associated with considerable distress in patient's daily life and significant impairments in health-related quality of life (QoL) [5, 6]. With quantitative or semi-quantitative methods, the changes in QoL in cough populations can be accurately analyzed. Commonly used validated instruments include the Cough Specific Quality of Life Questionnaire (CQLQ) [7], the Leicester Cough Questionnaire [8], and the Chronic Cough Impact Questionnaire [9]. These questionnaires have multiple items and domains and address the impact of cough on various aspects of health-related QoL, including physical, psychological, and social domains [10]. As such, QoL is closely affected by cough severity [11].
Most studies show a higher prevalence of nocturnal and non-productive cough in women than in men [12, 13]. Besides, previous studies have showed that physiology, physiopathology and outcome measures of cough differ in many ways between males and females [1420]. These could originate from gender-related differences not only in anatomy and physiology of respiratory, immune or nervous system, but also in behavioral and socio-cultural factors that considerably affect respiratory health [21]. However, whether the impact of cough on QoL is also variable between genders is still controversial.
Patients who complain a persistent cough lasting > 3 weeks after experiencing the acute symptoms of an upper respiratory tract infection may have a postinfectious cough. It is the most common cause of subacute cough, accounting for 30–50% of patients with subacute symptoms [22, 23]. We recently demonstrated that QingfengGanke granule improved clinical symptoms and cough specific QoL over placebo in patients with postinfectious cough [24]. Although a worse QoL has been reported in women with chronic cough than men [17], a similar cough related QoL between gender is demonstrated during acute conditions such as upper respiratory infections [25]. The gender difference in cough related QoL in subacute cough patients has not been studied yet.
In this post-hoc analysis, we sought to investigate that whether health related QoL was different among women and men, and whether female sex was a modifier in the association between cough severity and QoL among patients with postinfectious cough.

Methods

Study sample

The original trial was a multisite randomized controlled trial (Chinese Clinical Trial Registry: ChiCTRTRC12002297). Detailed study methods had been previously reported [11]. Briefly, a total of 180 eligible participants were randomly assigned to three groups to assess efficacy and safety of a Chinese herbal prescription in patients with postinfectious cough. All patients provided written informed consent and were recruited from five tertiary hospitals across China. The original trial was approved by the Medical Ethics Committee of West China Hospital of Sichuan University (Chengdu, China). Patient enrollment started in April 2011 and ended in March 2012. The current analysis included baseline data of all 180 participants.

Variables

Demographic variables including gender, age, and marital status were collected; body mass index was calculated based on the reported height and weight; clinical characteristics including previous physician-diagnosis of postinfectious cough, medication use for previous postinfectious cough attack, and cough duration were recorded; cough severity was measured by visual analogue scale (VAS), a widely used tool in clinical research and practice; cough symptom score assessed cough frequency, severity and the overall impact, and was evaluated in terms of daytime and nighttime intervals [26]; health related QoL was assessed using CQLQ at baseline. The questionnaire contains 28 items, each item being scored on a 4-point scale. All these items are summarized into six subscales: physical complaints, psychosocial issues, functional abilities, emotional well-being, extreme physical complaints, and personal safety fears. The score ranges from 28 and 112, with lower scores indicating a better QoL [7].

Statistical analysis

Baseline results were presented as mean (standard deviation) or median (interquartile range) for continuous variables as appropriate, and frequency (percentage) for categorical variables. Characteristics of women and men were compared using two-sample t test or Mann–Whitney U test for continuous variables and chi-square test for categorical variables.
Cough VAS and cough duration were included in the multiple linear regression model, based on their known or potential impact on QoL [25, 27, 28]. Clinical center was additionally adjusted for possible clustering effects. As current smokers and recent ex-smokers were excluded from the trial, smoke status was not included as a covariate. Daytime and nighttime cough symptom scores were also not included in the model because they captured cough severity and overall impact and might highly correlated with cough VAS. The interactions between gender and cough VAS in the association of total CQLQ were analyzed in the above-mentioned models. The multivariate linear regression analyses were repeated to assess the interaction between gender and cough VAS in the association of six subscales. Regression diagnostics were performed to examine the fit, multicollinearity and potentially influential observations.
A two-tailed P value < 0.05 was considered statistically significant. All analyses were performed using IBM SPSS Statistics version 21.0 (IBM, Armonk, NY).

Results

Demographic and clinical characteristics

A total of 104 women and 76 men were included in this study. There was no significant gender difference in age, body mass index and marital status. Women had longer cough duration than men did (32.6 days vs. 29.3 days, P = 0.035). Previous postinfectious cough history, medication use for previous cough attack, daytime and nighttime cough symptom score, cough VAS and CQLQ total score were not significantly different between women and men. The detailed demographics and clinical characteristics between women and men were shown in Table 1.
Table 1
Characteristics of women and men with postinfectious cough
Variables
Overall
(n = 180)
Women
(n = 104)
Men
(n = 76)
P value
Age (years), mean ± SD
44.3 ± 12.6
45.0 ± 12.1
43.3 ± 13.2
0.385
Body mass index (kg/m2), mean ± SD
23.4 ± 3.1
23.1 ± 3.0
23.8 ± 3.2
0.131
Married, n (%)
157 (87.2)
91 (87.5)
66 (86.8)
0.896
Medication use for previous PIC, n (%)
27 (15)
20 (19.2)
7 (9.2)
0.063
Ever previously diagnosed with PIC, n (%)
29 (16.1)
17 (16.3)
12 (15.8)
0.920
Cough duration (days), mean ± SD
31.2 ± 9.0
32.6 ± 9.7
29.3 ± 7.5
0.035
Cough symptom score, median (IQR)
Daytime
2 (2, 2)
2 (2, 2)
2 (2, 2)
0.379
Nighttime
2 (1, 2)
2 (1, 2)
2 (1, 2)
0.220
Cough VAS, median (IQR)
6 (5, 7)
6 (5, 7)
6 (5, 7)
0.060
CQLQ, mean ± SD
Total
64.5 ± 7.9
65.4 ± 7.4
63.3 ± 8.3
0.077
Physical complaints
21.5 ± 3.0
21.8 ± 2.8
21.1 ± 3.2
0.160
 Psychosocial issues
12.8 ± 2.1
12.9 ± 2.0
12.8 ± 2.3
0.723
 Functional abilities
11.1 ± 2.0
11.2 ± 1.9
11.0 ± 2.2
0.527
 Emotional well-being
7.2 ± 1.6
7.3 ± 1.6
7.0 ± 1.7
0.218
 Extreme physical complaints
8.6 ± 1.5
9.0 ± 1.5
8.1 ± 1.3
 < 0.001
 Personal safety fears
6.9 ± 1.7
7.0 ± 1.7
6.8 ± 1.7
0.562
CQLQ cough specific QoL questionnaire, IQR interquartile range, PIC postinfectious cough, VAS visual analogue scale

Gender difference in QoL

A higher mean score of extreme physical complaints was reported in women (9.0 vs. 8.1, P < 0.001). The difference between women and men was not significant in the score of total CQLQ and other five subscales in unadjusted analyses (Table 1). Women had a mean of 2.20-point higher CQLQ total score than men (95% confidence interval (CI) 0.11–4.30; P = 0.039), after adjusting for age, cough duration, cough VAS, and clinical center (R2 = 0.297). Female sex was significantly associated with a 0.88-point increase in extreme physical complaints score compared to men in the adjusted analysis (95% CI 0.47–1.28; P < 0.001). No significant difference between women and men was found in the other subscales analyses. Detailed differences in women versus men in the score of total CQLQ and six subscales in unadjusted and adjusted analyses were shown in Table 2.
Table 2
Gender differences in QoL in unadjusted and adjusted analyses
Variables
Unadjusted
Adjusted
Coefficient
95% CI
Coefficient
95% CI
Total CQLQ
2.10
 − 0.23
4.42
2.20*
0.11
4.30
Physical complaints
0.63
 − 0.25
1.51
0.63
 − 0.13
1.38
Functional abilities
0.19
 − 0.41
0.80
0.36
 − 0.22
0.95
Psychosocial issues
0.11
 − 0.51
0.73
0.24
 − 0.34
0.81
Emotional well-being
0.31
 − 0.18
0.80
0.38
 − 0.11
0.88
Extreme physical complaints
0.91*
0.50
1.33
0.88*
0.47
1.28
Personal safety fears
0.15
 − 0.36
0.65
 − 0.09
 − 0.54
0.37
*P < 0.05

Gender difference in the association between cough severity and QoL

The association between cough VAS and CQLQ total score was marginally significantly different between women and men in unadjusted analysis (coefficient 1.67, 95% CI − 0.02–3.36; P = 0.053). After adjusting for age, cough duration, and study center, gender significantly modified the association between cough VAS and CQLQ total score (coefficient 1.80, 95% CI 0.29–3.30; P = 0.020) (Table 3). An increase of 1-point in cough severity assessed by VAS was associated with a 2.55-point (95% CI 1.16–3.95) increase in CQLQ total score in women versus a 1.26-point (95% CI 0.20–2.31) increase in men (P = 0.020). Women had a higher mean CQLQ total score than men with a similar degree of cough severity (Fig. 1).
Table 3
Gender differences in association between VAS and QoL
Variables
Women
Men
Interaction
P value
Total CQLQ
 Unadjusted
2.40 (1.04, 3.76)
0.73 (− 0.32, 1.78)
1.67 (− 0.02, 3.36)
0.053
 Adjusted
2.55 (1.16, 3.95)
1.26 (0.20, 2.31)
1.80 (0.29, 3.30)
0.020
Physical complaints
 Unadjusted
0.99 (0.48, 1.50)
0.32 (− 0.07, 0.71)
0.67 (0.04, 1.30)
0.038
 Adjusted
1.12 (0.58, 1.66)
0.58 (0.21, 0.94)
0.76 (0.21, 1.30)
0.006
Functional abilities
 Unadjusted
0.59 (0.23, 0.96)
0.37 (0.11, 0.63)
0.23 (− 0.20, 0.66)
0.301
 Adjusted
0.37 (− 0.04, 0.77)
0.34 (0.05, 0.63)
0.17 (− 0.26, 0.59)
0.445
Psychosocial issues
 Unadjusted
0.66 (0.29, 1.03)
0.18 (− 0.10, 0.46)
0.48 (0.03, 0.93)
0.037
 Adjusted
0.73 (0.35, 1.11)
0.23 (− 0.06, 0.52)
0.42 (0.01, 0.84)
0.045
Emotional well-being
 Unadjusted
 − 0.02 (− 0.32, 0.28)
0.02 (− 0.21, 0.25)
 − 0.04 (− 0.41, 0.33)
0.839
 Adjusted
 − 0.12 (− 0.47, 0.23)
0.04 (− 0.21, 0.29)
 − 0.00 (− 0.37, 0.36)
0.985
Extreme physical complaints
 Unadjusted
0.19 (− 0.04, 0.42)
0.03 (− 0.18, 0.24)
0.16 (− 0.16, 0.47)
0.322
 Adjusted
0.24 (− 0.01, 0.50)
0.14 (− 0.08, 0.36)
0.20 (− 0.10, 0.50)
0.185
Personal safety fears
 Unadjusted
0.02 (− 0.28, 0.32)
 − 0.23 (− 0.47, 0.01)
0.25 (− 0.12, 0.63)
0.185
 Adjusted
0.18 (− 0.14, 0.50)
 − 0.12 (− 0.35, 0.11)
0.36 (0.03, 0.69)
0.034
Gender difference was significant in the association between VAS and physical complaints (coefficient 0.67, 95% CI 0.04–1.30; P = 0.038), and psychosocial issues (coefficient 0.48, 95% CI 0.03–0.93; P = 0.037). After adjusting for age, cough duration, and study center, gender difference was significant in the associations between VAS and physical complaints (coefficient 0.76, 95% CI 0.21–1.30; P = 0.006), psychosocial issues (coefficient 0.42, 95% CI 0.01–0.84; P = 0.045), and personal safety fears (coefficient 0.36, 95% CI 0.03–0.69; P = 0.034) (Table 3).

Discussion

To our knowledge, this study is the first attempt to examine gender difference in QoL and the association between cough VAS and QoL among patients with postinfectious cough. We found that female sex was associated with worse QoL than men, and female sex was a modifier in the association between cough severity and QoL among postinfectious cough patients.
The current study showed that an increase of 1-point cough VAS score was associated with a higher CQLQ total score in women than that in men, after adjusting for age, cough duration, and clinical center. To the best of our knowledge, this is the first study to report this association. The greater effect of cough on QoL in women may be due to higher scores in physical complaints, psychosocial issues, and personal safety fears. Coughing also causes other stressful and unpredictable occurrences, such as stress urinary incontinence, which is currently a social disease and predominantly affects women, leading to considerable physical and psychological morbidities [29, 30].
Although cough lasted longer in women than men, the change in CQLQ total score that was associated with one day increase in cough duration was not significantly different between women versus men in either unadjusted or adjusted analyses (data not shown). The lack of gender difference in the association between cough duration and CQLQ scores suggested that female gender might be not associated with worse QoL as cough lasted longer in postinfectious cough condition, which might be explained by the self-limiting property of postinfectious cough [31].
Inherent to the nature of the secondary analysis of existing data, our study has several limitations that warrant further discussions. First, cough frequency was not collected for the original analysis and therefore, was not included in the adjusting models. This unmeasured variable might confound the relationships addressed and, thus, result in a source of possible bias. Although the impact of objective cough frequency on health related QoL has been considered to be mild to moderate [32, 33], whether their association is different between women and men needs to be further investigated. Second, this study only included 180 patients among five sites in the same country. A larger sample size with more sites that distributed across different countries and regions would provide a more robust result allowing to uncover gender difference in the association between cough severity and QoL.

Conclusions

Among patients with postinfectious cough, women may experience worse QoL than men, and their QoL may be more markedly affected by cough symptom. Clinicians should be aware of the greater impact of cough on QoL in women, therefore, gender difference should be taken into account in the study of cough and cough related QoL.

Acknowledgements

Not applicable.
The original trial was approved by the Medical Ethics Committee of West China Hospital of Sichuan University (Chengdu, China). All participates agreed to participate and signed the written consent forms.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Frese T, Mahlmeister J, Deutsch T, Sandholzer H. Reasons for elderly patients GP visits: results of a cross-sectional study. Clin Interv Aging. 2016;11:127–32.CrossRef Frese T, Mahlmeister J, Deutsch T, Sandholzer H. Reasons for elderly patients GP visits: results of a cross-sectional study. Clin Interv Aging. 2016;11:127–32.CrossRef
2.
Zurück zum Zitat Månsson J, Nilsson G, Strender LE, Björkelund C. Reasons for encounters, investigations, referrals, diagnoses and treatments in general practice in Sweden—a multicentre pilot study using electronic patient records. Eur J Gen Pract. 2011;17:87–94.CrossRef Månsson J, Nilsson G, Strender LE, Björkelund C. Reasons for encounters, investigations, referrals, diagnoses and treatments in general practice in Sweden—a multicentre pilot study using electronic patient records. Eur J Gen Pract. 2011;17:87–94.CrossRef
3.
Zurück zum Zitat Axelsson M, Lindberg A, Kainu A, Rönmark E, Jansson SA. Respiratory symptoms increase health care consumption and affect everyday life—a cross-sectional population-based study from Finland, Estonia, and Sweden. Eur Clin Respir J. 2016;3:31024.CrossRef Axelsson M, Lindberg A, Kainu A, Rönmark E, Jansson SA. Respiratory symptoms increase health care consumption and affect everyday life—a cross-sectional population-based study from Finland, Estonia, and Sweden. Eur Clin Respir J. 2016;3:31024.CrossRef
4.
Zurück zum Zitat Young EC, Smith JA. Quality of life in patients with chronic cough. Ther Adv Respir Dis. 2010;4:49–55.CrossRef Young EC, Smith JA. Quality of life in patients with chronic cough. Ther Adv Respir Dis. 2010;4:49–55.CrossRef
5.
Zurück zum Zitat Chamberlain SA, Garrod R, Douiri A, Masefield S, Powell P, Bücher C, Pandyan A, Morice AH, Birring SS. The impact of chronic cough: a cross-sectional European survey. Lung. 2015;193:401–8.CrossRef Chamberlain SA, Garrod R, Douiri A, Masefield S, Powell P, Bücher C, Pandyan A, Morice AH, Birring SS. The impact of chronic cough: a cross-sectional European survey. Lung. 2015;193:401–8.CrossRef
6.
Zurück zum Zitat Dicpinigaitis PV, Eccles R, Blaiss MS, Wingertzahn MA. Impact of cough and common cold on productivity, absenteeism, and daily life in the United States: ACHOO Survey. Curr Med Res Opin. 2015;31:1519–25.CrossRef Dicpinigaitis PV, Eccles R, Blaiss MS, Wingertzahn MA. Impact of cough and common cold on productivity, absenteeism, and daily life in the United States: ACHOO Survey. Curr Med Res Opin. 2015;31:1519–25.CrossRef
7.
Zurück zum Zitat French CT, Irwin RS, Fletcher KE, Adams TM. Evaluation of a cough-specific quality-of-life questionnaire. Chest. 2002;121:1123–31.CrossRef French CT, Irwin RS, Fletcher KE, Adams TM. Evaluation of a cough-specific quality-of-life questionnaire. Chest. 2002;121:1123–31.CrossRef
8.
Zurück zum Zitat Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58:339–43.CrossRef Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58:339–43.CrossRef
9.
Zurück zum Zitat Baiardini I, Braido F, Fassio O, Tarantini F, Pasquali M, Tarchino F, Berlendis A, Canonica GW. A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. Allergy. 2005;60:482–8.CrossRef Baiardini I, Braido F, Fassio O, Tarantini F, Pasquali M, Tarchino F, Berlendis A, Canonica GW. A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. Allergy. 2005;60:482–8.CrossRef
10.
Zurück zum Zitat Vernon M, Leidy NK, Nacson A, Nelsen L. Measuring cough severity: perspectives from the literature and from patients with chronic cough. Cough. 2009;5:5.CrossRef Vernon M, Leidy NK, Nacson A, Nelsen L. Measuring cough severity: perspectives from the literature and from patients with chronic cough. Cough. 2009;5:5.CrossRef
11.
Zurück zum Zitat Kelsall A, Decalmer S, Webster D, Brown N, McGuinness K, Woodcock A, Smith J. How to quantify coughing: correlations with quality of life in chronic cough. Eur Respir J. 2008;32:175–9.CrossRef Kelsall A, Decalmer S, Webster D, Brown N, McGuinness K, Woodcock A, Smith J. How to quantify coughing: correlations with quality of life in chronic cough. Eur Respir J. 2008;32:175–9.CrossRef
12.
Zurück zum Zitat Björnsson E, Plaschke P, Norrman E, Janson C, Lundbäck B, Rosenhall A, Lindholm N, Rosenhall L, Berglund E, Boman G. Symptoms related to asthma and chronic bronchitis in three areas of Sweden. Eur Respir J. 1994;7:2146–53.CrossRef Björnsson E, Plaschke P, Norrman E, Janson C, Lundbäck B, Rosenhall A, Lindholm N, Rosenhall L, Berglund E, Boman G. Symptoms related to asthma and chronic bronchitis in three areas of Sweden. Eur Respir J. 1994;7:2146–53.CrossRef
13.
Zurück zum Zitat Lúdvíksdóttir D, Björnsson E, Janson C, Boman G. Habitual coughing and its associations with asthma, anxiety, and gastroesophageal reflux. Chest. 1996;109:1262–8.CrossRef Lúdvíksdóttir D, Björnsson E, Janson C, Boman G. Habitual coughing and its associations with asthma, anxiety, and gastroesophageal reflux. Chest. 1996;109:1262–8.CrossRef
14.
Zurück zum Zitat Fujimura M, Kasahara K, Kamio Y, Naruse M, Hashimoto T, Matsuda T. Female gender as a determinant of cough threshold to inhaled capsaicin. Eur Respir J. 1996;9:1624–6.CrossRef Fujimura M, Kasahara K, Kamio Y, Naruse M, Hashimoto T, Matsuda T. Female gender as a determinant of cough threshold to inhaled capsaicin. Eur Respir J. 1996;9:1624–6.CrossRef
15.
Zurück zum Zitat Dicpinigaitis PV, Rauf K. The influence of gender on cough reflex sensitivity. Chest. 1998;113:1319–21.CrossRef Dicpinigaitis PV, Rauf K. The influence of gender on cough reflex sensitivity. Chest. 1998;113:1319–21.CrossRef
16.
Zurück zum Zitat Dicpinigaitis PV, Allusson VR, Baldanti A, Nalamati JR. Ethnic and gender differences in cough reflex sensitivity. Respiration. 2001;68:480–2.CrossRef Dicpinigaitis PV, Allusson VR, Baldanti A, Nalamati JR. Ethnic and gender differences in cough reflex sensitivity. Respiration. 2001;68:480–2.CrossRef
17.
Zurück zum Zitat French CT, Fletcher KE, Irwin RS. Gender differences in health-related quality of life in patients complaining of chronic cough. Chest. 2004;125:482–8.CrossRef French CT, Fletcher KE, Irwin RS. Gender differences in health-related quality of life in patients complaining of chronic cough. Chest. 2004;125:482–8.CrossRef
18.
Zurück zum Zitat Birring SS, Pavord ID. Assessment of gender differences in health status with the Leicester Cough Questionnaire (LCQ). Thorax. 2009;64:1008–9.CrossRef Birring SS, Pavord ID. Assessment of gender differences in health status with the Leicester Cough Questionnaire (LCQ). Thorax. 2009;64:1008–9.CrossRef
19.
Zurück zum Zitat Kelsall A, Decalmer S, McGuinness K, Woodcock A, Smith JA. Sex differences and predictors of objective cough frequency in chronic cough. Thorax. 2009;64:393–8.CrossRef Kelsall A, Decalmer S, McGuinness K, Woodcock A, Smith JA. Sex differences and predictors of objective cough frequency in chronic cough. Thorax. 2009;64:393–8.CrossRef
20.
Zurück zum Zitat Lamprecht B, Vanfleteren LE, Studnicka M, Allison M, McBurnie MA, Vollmer WM, Tan WC, Nielsen R, Nastalek P, Gnatiuc L, et al. Sex-related differences in respiratory symptoms: results from the BOLD Study. Eur Respir J. 2013;42:858–60.CrossRef Lamprecht B, Vanfleteren LE, Studnicka M, Allison M, McBurnie MA, Vollmer WM, Tan WC, Nielsen R, Nastalek P, Gnatiuc L, et al. Sex-related differences in respiratory symptoms: results from the BOLD Study. Eur Respir J. 2013;42:858–60.CrossRef
21.
Zurück zum Zitat Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax. 1999;54:1119–38.CrossRef Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax. 1999;54:1119–38.CrossRef
22.
Zurück zum Zitat Kwon NH, Oh MJ, Min TH, Lee BJ, Choi DC. Causes and clinical features of subacute cough. Chest. 2006;129:1142–7.CrossRef Kwon NH, Oh MJ, Min TH, Lee BJ, Choi DC. Causes and clinical features of subacute cough. Chest. 2006;129:1142–7.CrossRef
23.
Zurück zum Zitat Lai K, Lin L, Liu B, Chen R, Tang Y, Luo W, Chen Q. Eosinophilic airway inflammation is common in subacute cough following acute upper respiratory tract infection. Respirology. 2016;21:683–8.CrossRef Lai K, Lin L, Liu B, Chen R, Tang Y, Luo W, Chen Q. Eosinophilic airway inflammation is common in subacute cough following acute upper respiratory tract infection. Respirology. 2016;21:683–8.CrossRef
24.
Zurück zum Zitat Jiang H, Mao B, Wang L, Zhang R, She B, Jin F, Xu Y, Ma J, Liu Q. The efficacy of QingfengGanke granule in treating postinfectious cough in pathogenic wind invading lungs syndrome: a multicenter, randomized, double-blind, placebo-controlled trial. Chin Med. 2015;10:21.CrossRef Jiang H, Mao B, Wang L, Zhang R, She B, Jin F, Xu Y, Ma J, Liu Q. The efficacy of QingfengGanke granule in treating postinfectious cough in pathogenic wind invading lungs syndrome: a multicenter, randomized, double-blind, placebo-controlled trial. Chin Med. 2015;10:21.CrossRef
25.
Zurück zum Zitat French CT, Fletcher KE, Irwin RS. A comparison of gender differences in health-related quality of life in acute and chronic coughers. Chest. 2005;127:1991–8.CrossRef French CT, Fletcher KE, Irwin RS. A comparison of gender differences in health-related quality of life in acute and chronic coughers. Chest. 2005;127:1991–8.CrossRef
26.
Zurück zum Zitat Wang MY, Liu H. The Chinese national guidelines on diagnosis and management of cough (December 2010). Chin Med J (Engl). 2011;124:3207–19. Wang MY, Liu H. The Chinese national guidelines on diagnosis and management of cough (December 2010). Chin Med J (Engl). 2011;124:3207–19.
27.
Zurück zum Zitat Lechtzin N, Hilliard ME, Horton MR. Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis. Chest. 2013;143:1745–9.CrossRef Lechtzin N, Hilliard ME, Horton MR. Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis. Chest. 2013;143:1745–9.CrossRef
28.
Zurück zum Zitat Wang K, Birring SS, Taylor K, Fry NK, Hay AD, Moore M, Jin J, Perera R, Farmer A, Little P, et al. Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial. Lancet Respir Med. 2014;2:35–43.CrossRef Wang K, Birring SS, Taylor K, Fry NK, Hay AD, Moore M, Jin J, Perera R, Farmer A, Little P, et al. Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial. Lancet Respir Med. 2014;2:35–43.CrossRef
29.
Zurück zum Zitat Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trøndelag. J Clin Epidemiol. 2000;53:1150–1157. Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trøndelag. J Clin Epidemiol. 2000;53:1150–1157.
30.
Zurück zum Zitat Fultz NH, Burgio K, Diokno AC, Kinchen KS, Obenchain R, Bump RC. Burden of stress urinary incontinence for community-dwelling women. Am J Obstet Gynecol. 2003;189:1275–82.CrossRef Fultz NH, Burgio K, Diokno AC, Kinchen KS, Obenchain R, Bump RC. Burden of stress urinary incontinence for community-dwelling women. Am J Obstet Gynecol. 2003;189:1275–82.CrossRef
31.
Zurück zum Zitat Braman SS. Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:138s–46s.CrossRef Braman SS. Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:138s–46s.CrossRef
32.
Zurück zum Zitat Schmit KM, Coeytaux RR, Goode AP, McCrory DC, Yancy WS Jr, Kemper AR, Hasselblad V, Heidenfelder BL, Sanders GD. Evaluating cough assessment tools: a systematic review. Chest. 2013;144:1819–26.CrossRef Schmit KM, Coeytaux RR, Goode AP, McCrory DC, Yancy WS Jr, Kemper AR, Hasselblad V, Heidenfelder BL, Sanders GD. Evaluating cough assessment tools: a systematic review. Chest. 2013;144:1819–26.CrossRef
33.
Zurück zum Zitat Birring SS, Matos S, Patel RB, Prudon B, Evans DH, Pavord ID. Cough frequency, cough sensitivity and health status in patients with chronic cough. Respir Med. 2006;100:1105–9.CrossRef Birring SS, Matos S, Patel RB, Prudon B, Evans DH, Pavord ID. Cough frequency, cough sensitivity and health status in patients with chronic cough. Respir Med. 2006;100:1105–9.CrossRef
Metadaten
Titel
Gender difference in the association between cough severity and quality of life among patients with postinfectious cough
verfasst von
Wei Liu
Qinqin Wu
Bing Mao
Hongli Jiang
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
Health and Quality of Life Outcomes / Ausgabe 1/2021
Elektronische ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-021-01680-5

Weitere Artikel der Ausgabe 1/2021

Health and Quality of Life Outcomes 1/2021 Zur Ausgabe